Topic tracker Pharma & Drug-Pricing Stock Trades in Congress
Drug-price negotiation, Medicare rules and FDA policy are written and overseen by Congress, mainly Energy & Commerce, Ways & Means, Senate Finance and HELP. This page tracks every disclosed congressional trade in drugmakers, biotechs, pharmacy benefit managers and health insurers, who makes them, and the bills in play.
Trades disclosed in the last 180 days · updated 2026-11-22 02:52 UTC · 25 of the tracked stocks were traded in this window.
Most-traded names
| Ticker | Company | Buys | Sells | Members | Last filed |
|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 4 | 9 | 6 | 2026-11-12 |
| ZTS | Zoetis Inc. | 8 | 3 | 4 | 2026-11-02 |
| LLY | Eli Lilly & Co. | 3 | 6 | 6 | 2026-11-12 |
| UNH | Unitedhealth Group Inc. | 3 | 6 | 5 | 2026-10-01 |
| BIIB | Biogen Inc. | 5 | 3 | 4 | 2026-10-01 |
| AMGN | Amgen Inc. | 2 | 5 | 2 | 2026-11-12 |
| MRNA | Moderna, Inc. | 3 | 2 | 3 | 2026-11-09 |
| MRK | Merck & Co. Inc. | 3 | 2 | 3 | 2026-11-02 |
| GILD | Gilead Sciences, Inc. | 4 | 1 | 4 | 2026-09-01 |
| NVO | Novo Nordisk A S | 2 | 2 | 3 | 2026-09-15 |
| MCK | Mckesson Corp. | 3 | 1 | 4 | 2026-09-01 |
| ABBV | Abbvie Inc. | 1 | 2 | 3 | 2026-09-18 |
| REGN | Regeneron Pharmaceuticals, Inc. | 2 | 1 | 3 | 2026-08-03 |
| COR | Cencora, Inc. | 1 | 2 | 2 | 2026-07-21 |
| HUM | Humana Inc. | 3 | 0 | 2 | 2026-07-21 |
| PFE | Pfizer Inc. | 2 | 0 | 1 | 2026-10-01 |
| VRTX | Vertex Pharmaceuticals Inc. / Ma | 1 | 1 | 2 | 2026-09-03 |
| AZN | Astrazeneca plc | 2 | 0 | 1 | 2026-07-21 |
| CVS | CVS Health Corp. | 2 | 0 | 2 | 2026-07-21 |
| GSK | Gsk plc | 1 | 0 | 1 | 2026-07-21 |
| SNY | Sanofi | 1 | 0 | 1 | 2026-07-21 |
| BMY | Bristol Myers Squibb Co. | 1 | 0 | 1 | 2026-07-21 |
| CAH | Cardinal Health Inc. | 1 | 0 | 1 | 2026-07-21 |
| ELV | Elevance Health, Inc. | 1 | 0 | 1 | 2026-07-21 |
| CI | Cigna Group | 1 | 0 | 1 | 2026-07-21 |
Who trades it
| Member | Chamber | Trades | Buys / sells |
|---|---|---|---|
| Alan Armstrongoversees | Senate | 21 | 21 / 0 |
| Rohit Khanna | House | 15 | 12 / 3 |
| Maria Elvira Salazar | House | 12 | 5 / 7 |
| David Taylor | House | 9 | 2 / 7 |
| Gilbert Cisneros | House | 8 | 6 / 2 |
| Thomas Keanoversees | House | 5 | 0 / 5 |
| Byron Donalds | House | 4 | 2 / 2 |
| John Boozmanoversees | Senate | 4 | 2 / 2 |
| Richard Dean McCormick | House | 4 | 0 / 4 |
| Jared Moskowitz | House | 4 | 2 / 2 |
| Kevin Hernoversees | House | 3 | 0 / 3 |
| Michael McCaul | House | 3 | 2 / 1 |
| Michael Rullioversees | House | 2 | 0 / 2 |
| Lloyd Doggettoversees | House | 2 | 2 / 0 |
| Dan Newhouse | House | 2 | 0 / 2 |
| Pete Sessionsoversees | House | 1 | 0 / 1 |
| Scott Franklin | House | 1 | 1 / 0 |
| Sheldon Whitehouseoversees | Senate | 1 | 0 / 1 |
| Thomas Tubervilleoversees | Senate | 1 | 1 / 0 |
| Rick Larsen | House | 1 | 1 / 0 |
Committees with jurisdiction
- House House Committee on Veterans' Affairs
- House House Committee on Energy and Commerce
- Senate Senate Committee on Veterans' Affairs
- Senate Senate Committee on Health, Education, Labor, and Pensions
See every committee's trading surface on the Committee Lens.
Related bills (last 12 months)
- HR 1520 — Charlotte Woodward Organ Transplant Discrimination Prevention Act (2026-11-20)
- HR 11137 — To amend the Internal Revenue Code of 1986 to authorize payment or reimbursement for coverage under certain dental service arrangements using amounts made available through health savings accounts and health flexible spending arrangements. (2026-11-20)
- HR 11133 — To require the Secretary of Veterans Affairs to conduct an epidemiological study of certain health effects that have been experienced by women veterans, and for other purposes. (2026-11-20)
- HR 11141 — To require the Administrator of the Drug Enforcement Administration to temporarily exempt buprenorphine from the Suspicious Orders Report System for the remainder of the opioid public health emergency. (2026-11-20)
- HR 11135 — To establish a grant to provide mental and behavioral health services and diversion programs to at-risk youth, and for other purposes. (2026-11-20)
- SRES 966 — A resolution designating November 19, 2026, as "National Rural Health Day". (2026-11-19)
- S 5795 — A bill to amend the Public Health Service Act to authorize grants to States, Indian Tribes, Tribal organizations, and political subdivisions thereof to hire, employ, train, and dispatch mental health professionals to respond in lieu of law enforcement officers in emergencies involving one or more persons with a mental illness or an intellectual or developmental disability, and for other purposes. (2026-11-19)
- HRES 1673 — Supporting the goals and ideals of "National Rural Health Day". (2026-11-19)
- HR 10887 — Protecting Consumer Access to Generic Drugs Act of 2026 (2026-10-22)
- HR 10874 — Medicare Low Income Subsidy Equality Act of 2026 (2026-10-22)
Latest disclosures
| Filed | Traded | Member | Ticker | Type | Amount | Source |
|---|---|---|---|---|---|---|
| 2026-11-12 | 2026-10-27 | Thomas Keanoversees | JNJ | SELL | $1K–$15K | ↗ filing |
| 2026-11-12 | 2026-11-03 | David Taylor | AMGN | SELL | $1K–$15K | ↗ filing |
| 2026-11-12 | 2026-11-03 | David Taylor | AMGN | SELL | $1K–$15K | ↗ filing |
| 2026-11-12 | 2026-11-03 | David Taylor | LLY | SELL | $1K–$15K | ↗ filing |
| 2026-11-12 | 2026-11-03 | David Taylor | LLY | SELL | $1K–$15K | ↗ filing |
| 2026-11-09 | 2026-10-20 | Gilbert Cisneros | LLY | BUY | $1K–$15K | ↗ filing |
| 2026-11-09 | 2026-10-20 | Gilbert Cisneros | MRNA | BUY | $1K–$15K | ↗ filing |
| 2026-11-04 | 2026-11-04 | Michael Rullioversees | LLY | SELL | $1K–$15K | ↗ filing |
| 2026-11-02 | 2026-10-02 | Rohit Khanna | MRK | BUY | $1K–$15K | ↗ filing |
| 2026-11-02 | 2026-10-13 | Rohit Khanna | ZTS | BUY | $1K–$15K | ↗ filing |
| 2026-11-01 | 2026-10-02 | Byron Donalds | ZTS | SELL | $1K–$15K | ↗ filing |
| 2026-11-01 | 2026-10-02 | Byron Donalds | ZTS | SELL | $1K–$15K | ↗ filing |
| 2026-10-09 | 2026-09-18 | Gilbert Cisneros | ZTS | BUY | $1K–$15K | ↗ filing |
| 2026-10-07 | 2026-09-30 | Thomas Keanoversees | JNJ | SELL | $1K–$15K | ↗ filing |
| 2026-10-05 | 2026-09-08 | Lloyd Doggettoversees | JNJ | BUY | $1K–$15K | ↗ filing |
| 2026-10-01 | 2026-09-11 | Rohit Khanna | MRNA | BUY | $1K–$15K | ↗ filing |
| 2026-10-01 | 2026-09-11 | Rohit Khanna | PFE | BUY | $1K–$15K | ↗ filing |
| 2026-10-01 | 2026-09-24 | Maria Elvira Salazar | BIIB | SELL | $1K–$15K | ↗ filing |
| 2026-10-01 | 2026-09-24 | Maria Elvira Salazar | MRK | SELL | $1K–$15K | ↗ filing |
| 2026-10-01 | 2026-09-24 | Maria Elvira Salazar | MRNA | SELL | $1K–$15K | ↗ filing |
| 2026-10-01 | 2026-09-24 | Maria Elvira Salazaroversees | UNH | SELL | $1K–$15K | ↗ filing |
| 2026-10-01 | 2026-09-22 | David Taylor | AMGN | BUY | $1K–$15K | ↗ filing |
| 2026-09-18 | 2026-09-14 | Pete Sessionsoversees | ABBV | SELL | $15K–$50K | ↗ filing |
| 2026-09-15 | 2026-08-31 | Kevin Hernoversees | NVO | SELL | $1K–$15K | ↗ filing |
| 2026-09-15 | 2026-09-10 | Kevin Hernoversees | NVO | SELL | $1K–$15K | ↗ filing |
| 2026-09-11 | 2026-08-20 | John Boozmanoversees | JNJ | SELL | $1K–$15K | ↗ eFD |
| 2026-09-10 | 2026-08-27 | Thomas Keanoversees | JNJ | SELL | $1K–$15K | ↗ filing |
| 2026-09-05 | 2026-08-28 | Michael McCaul | MRK | SELL | $50K–$100K | ↗ filing |
| 2026-09-03 | 2026-08-26 | David Taylor | AMGN | SELL | $1K–$15K | ↗ filing |
| 2026-09-03 | 2026-08-26 | David Taylor | AMGN | SELL | $1K–$15K | ↗ filing |
| 2026-09-03 | 2026-08-26 | David Taylor | VRTX | SELL | $1K–$15K | ↗ filing |
| 2026-09-02 | 2026-08-26 | Scott Franklin | NVO | BUY | $1K–$15K | ↗ filing |
| 2026-09-02 | 2026-08-12 | Sheldon Whitehouseoversees | AMGN | SELL | $1K–$15K | ↗ eFD |
| 2026-09-01 | 2026-08-07 | Rohit Khanna | MRK | BUY | $15K–$50K | ↗ filing |
| 2026-09-01 | 2026-08-07 | Rohit Khanna | JNJ | SELL | $1K–$15K | ↗ filing |
| 2026-09-01 | 2026-08-10 | Rohit Khanna | MCK | BUY | $1K–$15K | ↗ filing |
| 2026-09-01 | 2026-08-10 | Rohit Khanna | GILD | SELL | $1K–$15K | ↗ filing |
| 2026-09-01 | 2026-08-19 | Maria Elvira Salazar | MRK | BUY | $15K–$50K | ↗ filing |
| 2026-09-01 | 2026-08-19 | Maria Elvira Salazar | MRNA | SELL | $1K–$15K | ↗ filing |
| 2026-09-01 | 2026-08-19 | Maria Elvira Salazar | MRNA | BUY | $1K–$15K | ↗ filing |
Questions
- Which members of Congress trade pharma & drug pricing stocks?
- In the last 180 days, 23 members disclosed 106 trades in the stocks this tracker covers; the most-traded name was JNJ. The full list, with links to each original filing, is on this page.
- How many of these trades were made by members who oversee the sector?
- 32 of the 106 trades were made by members whose committees have jurisdiction over the company's sector. That is a transparency signal, not an accusation: many such trades are managed by advisers or held in trusts.
- Where does this data come from and how current is it?
- From the official US House Clerk and Senate electronic financial disclosures (periodic transaction reports). The law allows up to 45 days between a trade and its disclosure, so the most recent activity may not be public yet. The page rebuilds automatically.
- Is this investment advice?
- No. It is a record of publicly disclosed trades. Our own backtests show that blindly copying congressional trades does not reliably beat the market.
Other topic trackers
Source: official US House Clerk and Senate periodic transaction reports, committee rosters and congress.gov. Disclosures report amount ranges and can lag the trade by up to 45 days. A transparency record, not investment advice.